Detailed information for compound 1972395

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 396.478 | Formula: C22H21FN2O2S
  • H donors: 3 H acceptors: 2 LogP: 4.41 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: NCC(c1ccc(cc1F)c1c(O)cc(c2c1c1ccsc1c(=O)[nH]2)C)(C)C
  • InChi: 1S/C22H21FN2O2S/c1-11-8-16(26)17(12-4-5-14(15(23)9-12)22(2,3)10-24)18-13-6-7-28-20(13)21(27)25-19(11)18/h4-9,26H,10,24H2,1-3H3,(H,25,27)
  • InChiKey: IAJNJHDNCXBGCS-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens NIMA-related kinase 1 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Trichomonas vaginalis STE family protein kinase Get druggable targets OG5_127026 All targets in OG5_127026
Plasmodium berghei NIMA related kinase 4 Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania braziliensis protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Trypanosoma cruzi NIMA-related kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania major protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Toxoplasma gondii NEK kinase Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania mexicana protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Trypanosoma brucei Serine/threonine-protein kinase NEK16, putative Get druggable targets OG5_127026 All targets in OG5_127026
Plasmodium falciparum NIMA related kinase 2 Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania donovani Serine/threonine-protein kinase Nek1-related, putative Get druggable targets OG5_127026 All targets in OG5_127026
Plasmodium vivax serine/threonine-protein kinase NEK4, putative Get druggable targets OG5_127026 All targets in OG5_127026
Trypanosoma brucei NIMA-related protein kinase Get druggable targets OG5_127026 All targets in OG5_127026
Plasmodium vivax serine/threonine-protein kinase Nek1, putative Get druggable targets OG5_127026 All targets in OG5_127026
Trypanosoma cruzi Serine/threonine-protein kinase NEK16, putative Get druggable targets OG5_127026 All targets in OG5_127026
Giardia lamblia Kinase, NEK Get druggable targets OG5_127026 All targets in OG5_127026
Neospora caninum hypothetical protein Get druggable targets OG5_127026 All targets in OG5_127026
Plasmodium knowlesi NIMA related kinase 4, putative Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania major protein kinase, putative,serine/threonine-protein kinase Nek1, putative Get druggable targets OG5_127026 All targets in OG5_127026
Trypanosoma brucei gambiense protein kinase, putative,serine/threonine- protein kinase nek1, putative Get druggable targets OG5_127026 All targets in OG5_127026
Trypanosoma congolense NIMA-related protein kinase Get druggable targets OG5_127026 All targets in OG5_127026
Neospora caninum NEK kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania infantum protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania infantum protein kinase, putative,serine/threonine-protein kinase Nek1, putative Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania braziliensis serine/threonine-protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania donovani serine/threonine-protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Trypanosoma brucei gambiense protein kinase, putative,serine/threonine- protein kinase nek1, putative Get druggable targets OG5_127026 All targets in OG5_127026
Plasmodium falciparum NIMA related kinase 4 Get druggable targets OG5_127026 All targets in OG5_127026
Toxoplasma gondii NEK kinase Get druggable targets OG5_127026 All targets in OG5_127026
Trypanosoma cruzi protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania infantum serine/threonine-protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Echinococcus granulosus serine:threonine protein kinase Nek1 Get druggable targets OG5_127026 All targets in OG5_127026
Entamoeba histolytica serine/threonine protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Cryptosporidium hominis hypothetical protein Get druggable targets OG5_127026 All targets in OG5_127026
Trypanosoma cruzi Serine/threonine-protein kinase NEK11, putative Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania braziliensis protein kinase, putative,serine/threonine-protein kinase Nek1, putative Get druggable targets OG5_127026 All targets in OG5_127026
Schistosoma mansoni serine/threonine protein kinase Get druggable targets OG5_127026 All targets in OG5_127026
Babesia bovis protein kinase domain containing protein Get druggable targets OG5_127026 All targets in OG5_127026
Plasmodium knowlesi NIMA related kinase 2, putative Get druggable targets OG5_127026 All targets in OG5_127026
Trypanosoma cruzi Serine/threonine-protein kinase NEK11, putative Get druggable targets OG5_127026 All targets in OG5_127026
Plasmodium berghei NIMA related kinase 2 Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania mexicana serine/threonine-protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania mexicana protein kinase, putative,serine/threonine-protein kinase Nek1, putative Get druggable targets OG5_127026 All targets in OG5_127026
Trichomonas vaginalis CAMK family protein kinase Get druggable targets OG5_127026 All targets in OG5_127026
Trichomonas vaginalis CAMK family protein kinase Get druggable targets OG5_127026 All targets in OG5_127026
Neospora caninum hypothetical protein Get druggable targets OG5_127026 All targets in OG5_127026
Plasmodium yoelii hypothetical protein Get druggable targets OG5_127026 All targets in OG5_127026
Trypanosoma congolense protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Cryptosporidium parvum hypothetical protein Get druggable targets OG5_127026 All targets in OG5_127026
Toxoplasma gondii NEK kinase Get druggable targets OG5_127026 All targets in OG5_127026
Trichomonas vaginalis CAMK family protein kinase Get druggable targets OG5_127026 All targets in OG5_127026
Plasmodium yoelii Protein kinase domain Get druggable targets OG5_127026 All targets in OG5_127026
Echinococcus multilocularis serine:threonine protein kinase Nek1 Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania major serine/threonine-protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Schistosoma japonicum ko:K08857 NIMA (never in mitosis gene a)-related kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Trichomonas vaginalis CAMK family protein kinase Get druggable targets OG5_127026 All targets in OG5_127026
Neospora caninum hypothetical protein Get druggable targets OG5_127026 All targets in OG5_127026
Leishmania donovani protein kinase, putative Get druggable targets OG5_127026 All targets in OG5_127026
Trypanosoma brucei Serine/threonine-protein kinase NEK11, putative Get druggable targets OG5_127026 All targets in OG5_127026

By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Schistosoma mansoni serine/threonine protein kinase 0.0022 1 0.5
Trypanosoma brucei NIMA-related protein kinase 0.0022 1 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0022 1 0.5
Echinococcus granulosus serine:threonine protein kinase Nek1 0.0021 0 0.5
Echinococcus multilocularis serine:threonine protein kinase Nek1 0.0021 0 0.5
Trypanosoma cruzi Serine/threonine-protein kinase NEK11, putative 0.0022 1 1
Trichomonas vaginalis CAMK family protein kinase 0.0022 1 0.5
Trypanosoma cruzi Serine/threonine-protein kinase NEK11, putative 0.0022 1 1
Leishmania major serine/threonine-protein kinase, putative 0.0022 1 0.5
Toxoplasma gondii NEK kinase 0.0022 1 0.5
Plasmodium falciparum NIMA related kinase 4 0.0022 1 0.5
Trypanosoma cruzi NIMA-related kinase, putative 0.0022 1 1
Plasmodium vivax serine/threonine-protein kinase NEK4, putative 0.0022 1 0.5
Trypanosoma cruzi Serine/threonine-protein kinase NEK16, putative 0.0022 1 1
Leishmania major protein kinase, putative 0.0022 1 0.5
Toxoplasma gondii NEK kinase 0.0022 1 0.5
Leishmania major protein kinase, putative,serine/threonine-protein kinase Nek1, putative 0.0022 1 0.5
Trichomonas vaginalis STE family protein kinase 0.0022 1 0.5
Giardia lamblia Kinase, NEK 0.0022 1 0.5
Plasmodium vivax serine/threonine-protein kinase Nek1, putative 0.0022 1 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0022 1 0.5
Plasmodium falciparum NIMA related kinase 2 0.0022 1 0.5
Toxoplasma gondii NEK kinase 0.0022 1 0.5
Trichomonas vaginalis CAMK family protein kinase 0.0022 1 0.5
Trypanosoma brucei Serine/threonine-protein kinase NEK16, putative 0.0022 1 0.5
Trypanosoma brucei Serine/threonine-protein kinase NEK11, putative 0.0022 1 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 22 nM BindingDB_Patents: Kinase Assay. PBK activity was determined in the presence or absence of compounds using fluorescein isothiocyanate-labeled (FITC-labeled) histone H3 peptide as a substrate. The extent of FITC-labeled histone H3 peptide phosphorylation was measured by immobilized metal ion affinity-based fluorescence polarization (IMAP) technology (Sportsman J R, et al., Assay Drug Dev. Technol. 2: 205-14, 2004) using IMAP FP Progressive Binding System (Molecular Devices Corporation). Test compounds were dissolved in DMSO at 12.5 mM and then serially diluted as the DMSO concentration in the assays to be 1%. The serially diluted compounds, 0.8 ng/micro-L PBK (Carna Biosciences) and 100 nM FITC-labeled histone H3 peptide were reacted in a reaction buffer (20 mM HEPES, 0.01% Tween-20, 0.3 mM MgCl2, 2 mM dithiothreitol, 50 micro-M ATP, pH 7.4) at room temperature for 1 hour. The reaction was stopped by the addition of three fold assay volume of progressive binding solution. Following 0.5 hour incubation at room temperature. ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.